
Eternum · United States
Turn your clinic into a category leader.
The proven mentorship program that generated over R$ 1 billion in sales for more than 8,000 clinics across 10 countries. Now developed for ambitious clinic owners in the U.S. who are ready to scale beyond their own individual practice.


Founders
Everton & Bruna Pieri
Founders of Eternum. In Brazil, they built one of the most influential communities of high-performance clinic owners in the country. Over a decade, their method has served more than 8,000 clinics across 10 countries and generated over R$1 billion in sales for clients. Now they bring the same mentorship program to the United States, tailored for the clinic owner ready to scale beyond themselves.
Everton & Bruna Pieri · Founders
Proven, not theoretical
A mentorship program already validated at scale.
Everything we teach US clinic owners was pressure-tested for over a decade with clinics that grew from solo practices to nine-figure businesses.
In sales generated for clients
Clinics and clinicians served
Countries reached
Refining the program
Track record from Eternum's Brazilian operation. Same mentorship program, adapted to the US clinic market.
The mentors on the floor
The mentors standing between you and your next level.
Not gurus. Not coaches. Two mentors who have built, sold, and scaled real businesses.


What you get
Three levers. One outcome.
Offer & Sales
A high-ticket offer people are proud to buy, plus a sales process that converts predictably. The fastest levers for clinic revenue.
Led by Paul Kooiker
Brand, Systems & Execution
The brand that lets you stand out in a crowded market, and the systems and teams that scale without eating your calendar.
Led by Thais Junqueira
Founder Community
A room of peers building the same thing. Real conversations, real numbers, real accountability. The fastest shortcut in business.
Curated by Everton & Bruna
This is not for everyone.
Eternum US is built for clinic owners who are already good and are done being small. Applications open now for the first US cohort.





